Legal Representation
Attorney
CHRISTOPHER D. CASAVALE
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 24, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 24, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 6, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Aug 6, 2024 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Jul 19, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Jul 19, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Jun 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 22, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jun 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 18, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 25, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 25, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 25, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 25, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 25, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 21, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 21, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 10, 2024 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Jan 9, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jan 5, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 30, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 4, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Oct 4, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Aug 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 18, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 18, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 11, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 11, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 24, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 22, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 22, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 22, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 22, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 22, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 22, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 22, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 28, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 28, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 8, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 19, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 19, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 19, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 19, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 19, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 10, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 9, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Human cells for medical or clinical therapeutic purposes; cell growth media for growing specialized human cells for medical or clinical use; cell growth media for growing non-specialized human cells for medical or clinical use
Additional Information
Design Mark
The mark consists of a waypoint marker in the foreground disposed over an oval shaped shadow mark with four oval shaped shadow marks extending rearwardly into the distance.
Classification
International Classes
005